Unlikely to cause harm — often a labeling or packaging issue.
Labeling; Incorrect or Missing Lot and/or Exp Date; some bottles labeled with lot number 05318054B instead of 05318034B
| Brand name | SIMVASTATIN |
| Generic name | SIMVASTATIN |
| Active ingredient(s) | SIMVASTATIN |
| Distributed by / for | Aurobindo Pharma USA, Inc. Dayton, NJ 08810 |
| NDC | 65862-053-99 |
| Full product label | Simvastatin Tablets, USP 40 mg. Rx Only 1000 Count Bottles Manufactured by: Aurolife Pharma LLC Dayton NJ 08810 Manufactured for: Aurobindo Pharma USA, Inc. Dayton, NJ 08810 NDC 65862-053-99 |
| Recalling firm | Aurobindo Pharma USA Inc. |
| Distribution | Product was distributed nationwide by three major distributors who may have further distributed the product. |
| Quantity | 2,352/1000 count bottles |
| Recall initiated | 2019-07-29 |
| Report date | 2019-09-04 |
| Recall completed | 2021-10-28 |
| Recall number | D-1842-2019 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | East Windsor NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗